NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ)
· seekingalpha.com
NRx Pharmaceuticals (NRXP) stock jumps as the FDA completes the initial review of the company's preservative-free ketamine. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...